MD, Binzhou Medical College
PhD, National University of Singapore
1. suPAR and its implications in disease; 2. The pathogenesis of nephrotic syndrome; 3. The molecular mechanism of diabetic nephropathy
David Changli Wei, MD, PhD studies the molecular mechanisms of proteinuric kidney disease, a group of problems that are seemingly mild but often lead to chronic renal failure. Of the implicated molecules, he is particularly interested in the complexity of uPAR and has been exploring its roles in different diseases since 2004 together with Jochen Reiser, MD.